SNY financial statements
The full income statement, balance sheet, and cash-flow statement for Sanofi ADS (SNY), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.
Shares outstanding (point-in-time)
SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.
| Line item | Trend | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|---|
| Income Statement | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
38.1B YoY+13.2% | 33.6B YoY+7.3% | 31.4B YoY+4.0% | 30.2B YoY-5.3% | 31.8B YoY+10.8% | ||
| Research & development | 8.87B YoY+10.9% | 8.00B YoY+13.7% | 7.04B YoY+3.0% | 6.83B YoY+1.5% | 6.73B YoY+6.8% | |
| Operating income | 7.18B YoY-8.5% | 7.85B YoY+4.3% | 7.53B YoY-29.5% | 10.7B YoY+11.2% | 9.61B YoY-40.3% | |
| Interest expense | 637M YoY-45.1% | 1.16B YoY-17.0% | 1.40B YoY+209.3% | 452M YoY+3.9% | 435M YoY-1.6% | |
| Income tax | 1.18B YoY-9.4% | 1.30B YoY+18.5% | 1.10B YoY-45.2% | 2.01B YoY+8.9% | 1.84B YoY-10.5% | |
8.88B YoY+46.1% | 6.08B YoY+3.4% | 5.88B YoY-34.1% | 8.92B YoY+20.1% | 7.43B YoY-47.2% | ||
$7.21 YoY+50.3% | $4.79 YoY+3.1% | $4.65 YoY-33.6% | $7.00 | — | ||
| Balance Sheet | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
36.4B YoY-18.1% | 44.4B YoY+30.8% | 33.9B YoY-6.7% | 36.4B | — | ||
149B YoY+7.5% | 139B YoY-1.1% | 140B YoY+3.6% | 135B YoY-1.1% | 137B YoY-2.6% | ||
| Total current liabilities | 33.3B YoY+9.5% | 30.4B YoY+13.5% | 26.8B YoY+4.8% | 25.6B | — | |
| Long-term debt | 16.7B YoY+36.1% | 12.3B YoY-22.6% | 15.9B YoY+0.3% | 15.8B YoY-18.6% | 19.5B YoY-19.6% | |
83.8B YoY+3.7% | 80.8B YoY-1.4% | 81.9B YoY+2.8% | 79.7B YoY+2.2% | 78.0B YoY+0.9% | ||
| Cash Flow | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Cash from operations | 12.2B YoY+23.8% | 9.83B YoY-11.4% | 11.1B YoY+0.3% | 11.1B YoY-11.1% | 12.4B YoY+47.2% | |
| Acquisitions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Long-term debt issued | 6.29B | 0.00 YoY-100.0% | 51.9M YoY-96.8% | 1.63B | 0.00 YoY-100.0% | |
| Long-term debt repaid | 2.97B YoY+307.9% | 727M YoY-81.7% | 3.98B YoY+39.4% | 2.86B YoY+7.8% | 2.65B YoY-41.2% | |
| Common stock issued | 200M YoY-1.0% | 202M YoY-4.0% | 211M YoY+6.7% | 198M YoY-10.2% | 220M YoY-4.9% | |
| Common stock repurchased | 5.67B YoY+1636.2% | 327M YoY-49.0% | 641M YoY+22.7% | 522M YoY+15.6% | 452M YoY-51.8% | |
| Dividends paid | 5.40B YoY+6.1% | 5.09B YoY+5.7% | 4.82B YoY+9.9% | 4.38B YoY-7.6% | 4.74B YoY+5.6% | |
| Valuation Ratios | as ofDec 31 ’25 | as ofDec 31 ’24 | as ofDec 31 ’23 | as ofDec 31 ’22 | as ofDec 31 ’21 | |
| Market cap | 59.1B YoY-3.0% | 60.9B YoY-2.8% | 62.7B YoY+2.5% | 61.2B YoY-3.3% | 63.3B YoY+4.2% | |
| P/E | 6.7× YoY-33.6% | 10.0× YoY+42.5% | 7.0× YoY-14.7% | 8.2× YoY-3.3% | 8.5× YoY+97.1% | |
| P/B | 0.7× YoY-6.5% | 0.8× YoY-4.2% | 0.8× YoY+0.3% | 0.8× YoY-3.3% | 0.8× YoY+3.2% | |
15.0% YoY+50.6% | 10.0% YoY-29.8% | 14.2% YoY+17.2% | 12.1% YoY+3.4% | 11.7% YoY-49.3% | ||
9.2% YoY+8.5% | 8.4% YoY+9.0% | 7.7% YoY+7.1% | 7.2% YoY-4.3% | 7.6% YoY+2.2% | ||
| Source filing | 20-F | 20-F | 20-F | 20-F | 20-F |
About this data
Source: SNY's SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn't file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all SNY filings on SEC EDGAR → Not investment advice.
